Lynx1 Capital Management Lp's Net Worth
Lynx1 Capital Management Lp's net worth is estimated to be at least $3,582,769.91 as of 06/26/2025. CoreStreet's estimation of Lynx1 Capital Management Lp's net worth is based on their sale of stock and current holding of stock.
Lynx1 Capital Management Lp is Major Shareholder at Tscan Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,200,000 units of TCRX stock on 05/20/2025. Their biggest sale was on 05/31/2023 when they sold 25,400 units of Tscan Therapeutics Inc stock for $64,008.00. They typically trade 2 times per year.
Total value of insider buys:
- $3,518,761.91
Total value of insider sells:
- $64,008.00
Most recent insider trade:
- May 20, 2025
Lynx1 Capital Management Lp's Insider Trading History
| Tscan Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 20, 2025 | Major Shareholder | 1,200,000 | $1.20 | Buy | $1,440,000.00 |
May 19, 2025 | Major Shareholder | 1,388,794 | $1.20 | Buy | $1,666,552.80 |
Nov. 15, 2024 | Major Shareholder | 947 | $4.34 | Buy | $4,109.98 |
May 31, 2023 | Major Shareholder | 25,400 | $2.52 | Sell | $64,008.00 |
| Passage Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 27, 2024 | Major Shareholder | 373,645 | $0.65 | Buy | $242,869.25 |
Nov. 27, 2024 | Major Shareholder | 29,300 | $0.67 | Buy | $19,631.00 |
Nov. 25, 2024 | Major Shareholder | 259,998 | $0.56 | Buy | $145,598.88 |